T1	Treatment 129 141	chemotherapy
T2	Treatment 524 686	various analytic methods to evaluate the probability of response and identify independent predictors of progression-free survival (PFS) and overall survival (OS).
T3	Treatment 695 707	Single agent
T4	Treatment 711 744	combination chemotherapy regimens
T5	Treatment 755 770	doxorubicin (A)
T6	Treatment 778 799	doxorubicin/cisplatin
T7	Treatment 812 834	doxorubicin/paclitaxel
T8	Treatment 851 883	paclitaxel/doxorubicin/cisplatin
